Ellen de Brabander serves as the Executive Vice President of Innovation and Regulatory at Elanco Animal Health Inc., a leading global animal health company. With a robust background in pharmaceuticals and biotechnology, de Brabander has been instrumental in steering Elanco's innovation strategy and regulatory affairs. Before joining Elanco, she held significant leadership positions at major corporations, including her role as the Chief Scientific Officer at Covance, where she was responsible for overseeing global drug development and laboratory services. Her expertise in navigating complex regulatory environments and driving scientific advancements has been pivotal in her career. At Elanco, de Brabander's role encompasses leading the company's innovation pipeline, which includes the development of new products and technologies aimed at improving animal health and sustainability. Her leadership has been crucial in advancing Elanco's mission to enhance the health of animals and benefit the communities they serve. Under her guidance, Elanco has successfully launched several innovative products, such as the Seresto flea and tick collar, which have set new standards in pet care. De Brabander's strategic vision and commitment to excellence have earned her recognition within the industry and have significantly contributed to Elanco's growth and reputation as a leader in animal health. In addition to her professional achievements, Ellen de Brabander is known for her dedication to fostering a culture of continuous improvement and collaboration within Elanco. She actively engages with scientific communities and regulatory bodies to advocate for policies that support innovation in animal health. Her leadership style emphasizes teamwork and a shared commitment to advancing the company's goals, making her a respected figure both within Elanco and the broader industry. Through her efforts, de Brabander continues to drive Elanco's success and its impact on global animal health.